Blood pressure and hypertension: findings from 20 years of the Tehran lipid and glucose study [TLGS]
International Journal of Endocrinology and Metabolism. 2018; 16 (4 Supp.): 79-86
in English
| IMEMR
| ID: emr-204933
ABSTRACT
Context hypertension [HTN] is a well-known modifiable risk factor for cardiovascular disease [CVD], chronic kidney disease and mortality. Positive effects of blood pressure [BP] lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Controlled clinical trial
Language:
English
Journal:
Int. J. Endocrinol. Metab.
Year:
2018
Similar
MEDLINE
...
LILACS
LIS